Help support Chacruna’s team by being a sponsor

Chacruna.net is a hub for producing and disseminating high-quality multimedia content about plant medicines and psychedelics, facilitating access to these resources online. The website’s central objective is to offer content created and curated by leading experts in the field, edited to a wider audience. The field of psychedelics is filled with misinformation, anecdotal narratives, poorly trained professionals and enthusiasts with no field experience, leading discussions with large audiences of novices to the subject.

Chacruna Press Release

Chacruna.net is proud to announce the release of the Statement on Open Science and Open Praxis with Psilocybin, MDMA, and Similar Substances, to which we are a signatory.

Robert Jesse, psychedelic researcher, led the development of the statement, which reflects the history, commitment, and hopes of leaders and organizations in the field of psychedelic research and therapy.

The statement is intended to promote key principles in the research and development of psychedelic medicines, including intellectual and scientific integrity, service, open science and open practices, and non-interference. This document was developed in response to concerns that, as psilocybin and MDMA progress through clinical trials showing promise as medicines, commercial enterprises will form in ways that incentivize them to not share materials or knowledge, to prioritize profits, or to act competitively against others.

For the past century, the field of psychedelics has been marked by cooperation over competition, including the open sharing of knowledge, methods and best practices, and materials. With commercial enterprises taking an interest in psychedelics, journalists, stakeholders, and the general public may need to ask critical questions: Will the new businesses move away from this heritage? Will they seek to interfere with or compete with each other? Do they use exclusive contracts and partnerships to restrict collaboration, sharing of information, or access to materials? Will they assert patent rights? Will they seek regulatory approvals that are tailored to serve the applicant’s financial interests while effectively locking others out? Will they follow the tradition of modest, cost-plus pricing? Or will they employ value-based pricing, charging what the market will bear after potential “competition” has been minimized?

The statement had been signed by numerous scholars, researchers, and practitioners; psychedelic research and service organizations; and philanthropists and foundations. Journalists seeking more information or professionals interested in adding their signature to the statement may write to Bob Jesse: osop@bobjesse.com.

Chacruna.net:

Additional signatories:

STATEMENT ON OPEN SCIENCE AND OPEN PRAXIS WITH PSILOCYBIN, MDMA, AND SIMILAR SUBSTANCES

Preamble: The undersigned individuals and organizations work to advance the understanding and beneficial uses of substances called (among many names) psychedelics, hallucinogens, or entheogens. Our fields include medicine and traditional healing, medicinal chemistry and ethnopharmacology, psychopharmacology, neuroscience, psychology, counseling, religion, public health, and public policy.

From generations of practitioners and researchers before us, we have received knowledge about these substances, their risks, and ways to use them constructively. In turn, we accept the call to use that knowledge for the common good and to share freely whatever related knowledge we may discover or develop.

Therefore, in this work, we commit to the following principles. If we engage with consultants, contractors, or suppliers, we will do so in ways that uphold these principles.

1. Intellectual and scientific integrity. We affirm that we report the truth as we find it, not as we or others might prefer it to be found. We will present disappointing or adverse results as well as affirming or encouraging ones. We will properly attribute the contributions of others.

2. In service. While we may need to be paid for our labor, we are called to this work in the spirit of service. We will place the common good above private gain, and we will work for the welfare of the individuals and communities served. We will strive to make our expertise and services available to all who may benefit from them, even those whose means are limited.

3. Open science and open praxis. We will not withhold, nor will we require others to withhold, materials or knowledge (experiences, observations, discoveries, methods, best practices, or the like) for commercial advantage. This does not preclude the appropriate management of raw data or the exercise of data exclusivity rights, but we will make those decisions for the common good rather than for private gain. Nor does this preclude reasonable and ordinary charges for our books, other media, software, materials, or professional services.

4. Non-interference. We will strive to place our discoveries into the public domain, for the benefit of all. If we have patents or patents pending, we will license that intellectual property, for no more than reasonable and ordinary administrative costs, to anyone who will use it for the common good and in alignment with these principles.

Signatories may refine or expand their commitments, broadly in keeping with these principles, via further public statements. This document is an evolving work, with signatures being added. They are provisional pending a final release.

Clerk: Robert Jesse. Please email osop@bobjesse.com if you’d like yourself or your organization to be included.

Scientists, scholars, and practitioners:

Signatories

Affiliations listed for identification only

Ram Dass

Richard Alpert, PhD

Ralph Metzner, PhD

Green Earth Foundation

James Fadiman, PhD

Ann Shulgin

Alexander Shulgin Research Institute

George Greer, MD

Heffer Research Institute

Dennis McKenna, PhD

Heffter Research Institute

Charles S. Grob, MD

UCLA School of Medicine

Harriet de Wit, PhD

University of Chicago

Thomas B Roberts, PhD

Northern Illinois University

Frederick S. Barret, PhD

University of Chicago

Mary P. Cosimano, MSW

Johns Hopkins University School of Medicine

Alan K. Davis, PhD

Johns Hopkins University School of Medicine

Albert Garcia-Romeu, PhD

Johns Hopkins University School of Medicine

Roland R. Griffiths, PhD

Johns Hopkins University School of Medicine

Darrick G. May, PhD

Johns Hopkins University School of Medicine

Brian D. Richards, PsyD

Johns Hopkins University School of Medicine

William A. Richards, PhD

Johns Hopkins University School of Medicine

Janis Phelps

California Institue of Integral Studies

Kathleen Harrison

Botanical Dimensions

Torsten Passie, MD, MA (phil.)

Hannover Medical School

Katherine A. MacLean, PhD

Michael P. Bogenschultz, MD

New York University

Anthony P. Bossis, PhD

New York University

Jeffrey R. Guss, MD

New York University

Mark A.R. Kleiman, PhD

New York University

Stephen Ross, MD

New York University

Robin Carhart-Harris, PhD

Imperial College London

Mendel Kaelen, PhD

Imperial College London & Wavepaths

Taylor Lyons, PhD (cand.)

Imperial College London

Jonny Martel, MRCP

Imperial College London

Roberta Murphy, MD

Imperial College London

Leor Roseman, PhD

Imperial College London

Ben Sessa, MD

Imperial College London

Christopher Timmermann, PhD (cand)

Imperial College London

Rosalind Watts, DClinPsy

Imperial College London

David Luke, PhD

University of Greenwich

Rita Kočárová, PhD. (cand.)

National Institute of Mental Health, Czech Republic

Tomáš Páleníček, MD, PhD

National Institute of Mental Health, Czech Republic

Filip Tylš, MD, PhD

National Institute of Mental Health, Czech Republic

Miroslav Horák, PhD

Mendel University, Cech Republic

Peter S. Hendricks, PhD

University of Alabama at Birmingham

Brian T. Anderson, MD, MSc

UCSF - University of California, San Francisco

Christopher S. Stauffer, MD

UCSF - University of California, San Francisco

Emily Williams

UCSF - University of California, San Francisco

Alexander B. Belser, PhD (cand.)

Yale University

Benjamin Kelmendi, MD

Yale School of Medicine

Jordan Sloshower, MD MSc

Yale School of Medicine

Rick Doblin, PhD

MAPS

Amy Emerson

MAPS Public Benefit Corp.

Allison Feduccia, PhD

MAPS Public Benefit Corp.

Lisa Jerome, PhD

MAPS Public Benefit Corp.

Ann Mithoefer, BSN

MAPS Public Benefit Corp.

Michael Mithoefer, MD

MAPS Public Benefit Corp.

Berra Yazar-Klosinski, PhD

MAPS

Charles L. Raison, MD

Usona Institue & Med. U. of S. Carolina

Gabor Maté, MD

Simon Fraser University

Adele Getty

Limina Foundation

Jason C. Slot, PhD

Ohio State University

Amanda Feilding

The Beckley Foundation

Matthias E. Liechti, MD, MAS

University Hospital Basel

José Carlos Bouso, PhD

ICEERS, Barcelona

Dráulio Araújo, PhD

Federal University of Rio Grande do Norte, Brazil

Beatriz Labate, PhD

CIIS/CIESAS

Geoff Bathje, PhD

Adler Univeristy, Chicago

Alan Cohn, MD

ECfES.org

James J. Franzo-Eclipse

ECfES.org

Vip B. Short, DC

ECfES.org

Sophia Korb, PhD

Martin Williams, PhD

PRISM, Australia

Gabrielle Agin-Liebes, PhD (cand.)

Palo Alto University

Eric Osborne, MA Ed.

MycoMeditations LLC and PLEDG Inc.

Sunil Kumar Aggarwal, MD, PhD, FAAPMR

University of Washington

Angela Beers, PsyD

shadowmedicine.com

Eleonora Molnar, MA

Women’s Visionary Congress, Canada

Paul Abramson, MD

My Doctor Medical Group & UCSF

Leia Friedman, MS

The Psychedologist

Daniel McQueen, MA

Medicinal Mindfulness

Riccardo Vitale, PhD

UMIYAC, Cartagena, Columbia

Iker Puente, PhD

Barcelona

Rafael Lancelotta

University of Wyoming

Julie Holland, MD

Matthew Brown, DO, MBA

Psych Arts

Sonja Styk, Dr.Med.

Swiss Medical Society for Psycholytic Therapy

Juraj Styk, Dr.Med.

Swiss Medical Society for Psycholytic Therapy

Kevin Franciotti

The New School, New York

Kyle Buller

Psychedelics Today

Meghan Kennedy, LCSW

SuiteEthos, Chicago

Henrik Jungaberle, Dr.sc.hum.

MIND Foundation

Kelan Thomas, PharmD, MS

Touro University California & UCSF

Andrew Penn, MS, NP

UCSF & Kaiser Permanente

Mary McDermott, MFT

Erika Masak-Goldman, LMFT

EMG Clinical Group

Elena Felder, MFT

Efrem Nulman, PhD

Wellness Enterprise

Raymond C. Turpin, PsyD

(Smoky Mountain Psychological Services, PLLC)

Jessica L. Nielson, PhD

(University of Minnesota Medical School)

Heather L. Walker, PhD

Luís Fernando Tófoli

(University of Campinas, Brazil)

Sidarta Ribeiro, PhD

(Federal Univ. of Rio Grande do Norte Natal, Brazil)

K. Casey Alexander Paleos, MD

(New York, NY)

Ray Worthy, PhD, MD

(New Orleans, LA)

Research and service organizations:

Signatories

Multidisciplinary Association for Psychedelic Studies

MAPS

Heffter Research Institute

The Beckley Foundation

Erowid Center

Usona Institute

see usonainstitute.org/openscience

Botanical Dimensions

California Institute of Integral Studies

CIIS

Wavepaths, Ltd.

Chacruna.net

Eugene Center for Ethnobotanical Studies

ECfES.org

Psychedelic Research In Science & Medicine

prism.org.au

Union of Indigenous Yage Medics of the Colombian Amazon

UMIYAC

Khanyisa Healing Gardens NPC, South Africa

International Center for Ethnobotanical Education Research & Service

ICEERS

OPEN Foundation

www.stichtingopen.nl

Medicinal Mindfulness, LLC

Heroic Hearts Project

Earth Medicine Institute

Psychedelics Today

MIND European Foundation for Psychedelic Science

Psychedelic societies and integration circles

Signatories

Label 2

Psychedelic Safety, Support, and Integration, Chicago

Chicago Psychedelic Community

The Psychedelic Society, UK

Portland Psychedelic Society

The Psychedelic Society Germany

Australian Psychedelic Society

Art of Waking Up

Los Angeles

AsiaTripper

Taiwan, HongKong, etc.

Czech Psychedelic Society

czeps.org/en

Supporters, Organizers, publishers, conferences

Signatories

Label 2

Psymposia

Beyond Psychedelics

Czech Republic

Psychedelics and the Future of Psychiatry, Chicago

Melissa Warner

PRISM & Australian Psychedelic Society

Mike Margolies

Joost J. Breeksema, MA

OPEN Foundation, Netherlands

Eric N. Codner, DC

Columbus Physical Medicine Center

Jake Tracy

Michigan State University

Vincent Zeolla, PT, DPT

4D Health & Performance Center)

4D Health & Performance Center

Norwalk, CT

www.drugscience.de

Philanthropists and philanthropic foundations:

Signatories

Robert J. Barnhart

CSP Fund

Betsy Gordon

Bill Linton

Carey and Claudia Turnbull

Riverstyx Foundation

Dr. Bronner’s

George Sarlo Foundation

Evolve.Foundation

Source Research Foundation

The most current version of this statement can be found at csp.org/open.

Help support Chacruna's team by being a sponsor

Chacruna.net is a hub for producing and disseminating high-quality multimedia content about plant medicines and psychedelics, facilitating access to these resources online. The website's central objective is to offer content created and curated by leading experts in the field, edited to a wider audience. The field of psychedelics is filled with misinformation, anecdotal narratives, poorly trained professionals and enthusiasts with no field experience, leading discussions with large audiences of novices to the subject.